Related Experiment Video
Updated: May 13, 2026

Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens
Published on: March 10, 2020
Campylobacter jejuni Bacteremia in an Immunocompromised Host: A Rare Case Report
Vismay Patel1, Hassan Waheed1, Rubba S Khan1
1Internal Medicine, Hudson Regional Health (HRH) Bayonne University Hospital, Bayonne, USA.
Abstract:
Campylobacter jejuni is a common cause of bacterial gastroenteritis and typically produces a self-limited illness in immunocompetent hosts. Bacteremia is rare and is usually described in patients with immunosuppression or significant comorbidities, with risk for severe systemic complications if diagnosis is delayed. We report a case of Campylobacter jejuni bacteremia in a 41-year-old man with type 2 diabetes mellitus, coronary artery disease, hypertension, hyperlipidemia, and obstructive sleep apnea who presented with fever, chills, and profuse watery diarrhea after consuming convenience-store food. Blood cultures obtained at an outside facility later grew C. jejuni. By the time of admission, gastrointestinal symptoms had been resolved, and he was hemodynamically stable. Laboratory evaluation showed normal leukocyte count and mild transaminitis, and computed tomography demonstrated ileocecal enterocolitis. He was treated with azithromycin, and repeat blood cultures were negative; he achieved complete clinical recovery. This case emphasizes the importance of reviewing pending blood culture results and initiating timely macrolide therapy to prevent systemic complications. This case is notable for delayed bacteremia despite resolution of gastrointestinal symptoms and highlights the importance of reviewing pending blood culture results.
Related Concept Videos
Bacterial Gastroenteritis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Pyelonephritis I: Introduction
